查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1356800

影像生物標記市場報告：2030 年趨勢、預測與競爭分析

Imaging Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

成像生物標記趨勢和預測

預計到 2030 年，全球成像生物標記市場將達到約 177 億美元，2024 年至 2030 年的年複合成長率為 14.6%。該市場的主要促進因素是慢性病例數量的增加、成像生物標記虛擬和巨量資料技術等技術突破以及全球醫療保健意願的增強。全球影像生物標記市場的未來充滿希望，在個人化醫療、藥物研發開拓、分子診斷、藥物配方、疾病診斷和法醫學市場方面存在機會。

成像生物標記市場洞察

Lucintel 預測，磁振造影在預測期內將繼續成為最大的細分市場，因為它有助於檢測脊髓病變、癌症、血管疾病和腦部疾病。

疾病診斷將繼續成為最大的細分市場，因為它能夠對新藥達到預期目標的患者群體進行表徵。

由於人們對該疾病的認知不斷提高以及技術進步不斷進步，北美在預測期內可能仍將是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球成像生物標記市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球成像生物標記市場趨勢（2018-2023）與預測（2024-2030）
  • 按技術分類的全球成像生物標記市場
    • 正子斷層掃描
    • 超音波
    • 磁振造影
    • CT檢查
    • 單光子發射電腦斷層掃描
    • 其他
  • 按應用分類的全球成像生物標記市場
    • 個人化醫療
    • 藥物研發發現與開發
    • 分子診斷
    • 藥物製劑
    • 疾病診斷
    • 法醫應用
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球成像生物標記市場（按地區）
  • 北美影像生物標記市場
  • 歐洲影像生物標記市場
  • 亞太地區成像生物標記市場
  • 其他區域成像生物標記市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球成像生物標記市場成長機會（按技術）
    • 全球成像生物標記市場成長機會（按應用）
    • 按地區分類的全球成像生物標記市場成長機會
  • 全球成像生物標記市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球成像生物標記市場的產能
    • 全球成像生物標記市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Siemens Healthineers
  • ICON
  • Invicro
  • Median Technologies
  • PI Solutions
  • IXICO
  • Bioxydyn
  • Zionexa
  • Imabiotech
  • BRAINOMIX
簡介目錄

Imaging Biomarker Trends and Forecast

The future of the global imaging biomarker market looks promising with opportunities in the personalized medicine, drug discovery and development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets. The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are the rise in cases of chronic cases, technological breakthroughs like virtualization of imaging biomarkers and big data technologies, and increasing inclination towards healthcare across the globe.

A more than 150-page report is developed to help in your business decisions.

Imaging Biomarker by Segment

The study includes a forecast for the global imaging biomarker by technology, application, and region.

Imaging Biomarker Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Positron Emission Tomography
  • Ultrasound
  • Magnetic Resonance Imaging
  • Computed Tomography
  • Single-Photon Emission Computed Tomography
  • Others

Imaging Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Personalized Medicines
  • Drug Discovery and Development
  • Molecular Diagnostics
  • Drug Formulation
  • Disease Diagnosis
  • Forensic Applications
  • Others

Imaging Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Imaging Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies imaging biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the imaging biomarker companies profiled in this report include-

  • Siemens Healthineers
  • Icon
  • Invicro
  • Median Technologies
  • Pi Solutions
  • Ixico
  • Bioxydyn
  • Zionexa
  • Imabiotech
  • Brainomix

Imaging Biomarker Market Insights

Lucintel forecasts that magnetic resonance imaging will remain the largest segment over the forecast period as it aids in detecting spinal lesions, cancers, and vascular and brain disorders.

Disease diagnosis will remain the largest segment due to their ability to enable the characterization of patient populations to which new drugs reach intended targets.

North America will remain the largest region over the forecast period due to increasing awareness of the disease and growing technological advancements in the region.

Features of the Global Imaging Biomarker Market

Market Size Estimates: Imaging biomarker market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Imaging biomarker market size by technology, application, and region. in terms of value ($B).

Regional Analysis: Imaging biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, applications, and region.s for the imaging biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the imaging biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the imaging biomarker market size?

Answer: The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030.

Q.2. What is the growth forecast for imaging biomarker market?

Answer: The global imaging biomarker market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the imaging biomarker market?

Answer: The major drivers for this market are the rise in cases of chronic cases, technological breakthroughs like virtualization of imaging biomarkers and big data technologies, and increasing inclination towards healthcare across the globe.

Q.4. What are the major segments for imaging biomarker market?

Answer: The future of the global imaging biomarker market looks promising with opportunities in the personalized medicine, drug discovery and development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets.

Q.5. Who are the key imaging biomarker market companies?

Answer: Some of the key imaging biomarker companies are as follows:

  • Siemens Healthineers
  • ICON
  • Invicro
  • Median Technologies
  • PI Solutions
  • IXICO
  • Bioxydyn
  • Zionexa
  • Imabiotech
  • BRAINOMIX

Q.6. Which imaging biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that magnetic resonance imaging will remain the largest segment over the forecast period as it aids in detecting spinal lesions, cancers, and vascular and brain disorders.

Q.7. In imaging biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing awareness of the disease and growing technological advancements in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the imaging biomarker market by technology (positron emission tomography, ultrasound, magnetic resonance imaging,computed tomography, single-photon emission computed tomography, and others) application (personalized medicines, drug discovery and development, molecular diagnostics, drug formulation, disease diagnosis, forensic applications, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Imaging Biomarker Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Imaging Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Imaging Biomarker Market by Technology
    • 3.3.1: Positron Emission Tomography
    • 3.3.2: Ultrasound
    • 3.3.3: Magnetic Resonance Imaging
    • 3.3.4: Computed Tomography
    • 3.3.5: Single-Photon Emission Computed Tomography
    • 3.3.6: Others
  • 3.4: Global Imaging Biomarker Market by Application
    • 3.4.1: Personalized Medicines
    • 3.4.2: Drug Discovery and Development
    • 3.4.3: Molecular Diagnostics
    • 3.4.4: Drug Formulation
    • 3.4.5: Disease Diagnosis
    • 3.4.6: Forensic Applications
    • 3.4.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Imaging Biomarker Market by Region
  • 4.2: North American Imaging Biomarker Market
    • 4.2.2: North American Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
  • 4.3: European Imaging Biomarker Market
    • 4.3.1: European Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
    • 4.3.2: European Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
  • 4.4: APAC Imaging Biomarker Market
    • 4.4.1: APAC Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
    • 4.4.2: APAC Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
  • 4.5: ROW Imaging Biomarker Market
    • 4.5.1: ROW Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
    • 4.5.2: ROW Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Othersers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Imaging Biomarker Market by Technology
    • 6.1.2: Growth Opportunities for the Global Imaging Biomarker Market by Application
    • 6.1.3: Growth Opportunities for the Global Imaging Biomarker Market by Region
  • 6.2: Emerging Trends in the Global Imaging Biomarker Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Imaging Biomarker Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Imaging Biomarker Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Siemens Healthineers
  • 7.2: ICON
  • 7.3: Invicro
  • 7.4: Median Technologies
  • 7.5: PI Solutions
  • 7.6: IXICO
  • 7.7: Bioxydyn
  • 7.8: Zionexa
  • 7.9: Imabiotech
  • 7.10: BRAINOMIX